| ZRG1 CDPT-E (81) |
PAR Panel: Oncological Sciences (R15 and R16) |
Dr. Elisaveta Voynova |
| ZRG1 CDPT-F (55) |
PAR Panel: Diet, Lipid Metabolism, and Cancer |
Dr. Shree Ram Singh |
| ZRG1 CDPT-F (56) |
PAR-24-274: NCI Research Specialist Award (R50) |
Dr. Shree Ram Singh |
| ZRG1 CDPT-H (55) |
PAR Panel: Cancer Etiology, Diagnosis, Prevention and Treatment |
Dr. Hasan Siddiqui |
| ZRG1 CDPT-Q (80) |
PAR Panel: Exploratory Research in Cancer Prevention and Therapeutics (R21) |
Dr. Jun Fang |
| ZRG1 CDPT-R (55) |
PAR Panel: Biomarkers, Immunotherapy, and Biospecimen Science Technologies |
Dr. Robert Gahl |
| ZRG1 CDPT-Y (82) |
Immune Oncology Research (R21) |
Dr. Zhiqiang Zou |
| ZRG1 CDPT-Z (02) |
Member Conflict: Cancer Prevention and Therapeutics |
Dr. Ola Mae Howard |
| ZRG1 CN-K (55) |
PAR Panel: Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Dr. Aleksey Kazantsev |
| ZRG1 CN-K (95) |
Biomarker Studies in Neuroscience |
Dr. Aleksey Kazantsev |
| ZRG1 CN-M (82) |
Neurodevelopmental and Neuropsychiatric Disorders |
Dr. Patricia Kraemer |
| ZRG1 CN-Q (85) |
Immune Signaling in Neurological Disorders and Infectious Diseases |
Dr. Iqbal Sayeed |
| ZRG1 CN-U (55) |
RFA Panel: Optimizing Treatment Strategies for Adult ADHD |
Dr. Chi-Tso Chiu |
| ZRG1 CN-W (54) |
PAR's Panel: Rare Diseases Clinical Research Consortia |
Dr. Anita Tandle |
| ZRG1 CN-Y (81) |
Brain Injury and Neurodegeneration |
Dr. Alexander Yakovlev |
| ZRG1 CTH-H (50) |
PAR-23-242: NCI Research Specialist (Laboratory-based Scientist) Award (R50) |
Dr. Bruce Hissong |
| ZRG1 CTH-H (80) |
Mechanisms of Cancer Therapeutics Special Emphasis Panel. |
Dr. Bruce Hissong |
| ZRG1 CTH-N (55) |
PAR-24-306: Mammalian Models |
Dr. Susan Spence |
| ZRG1 CTH-P (40) |
IDeA Clinical and Translational Research Development (CTR-D) Award (P20/P50) |
Dr. Michael Opata |
| ZRG1 CTH-Q (45) |
Program Project: Cancer Research |
Dr. Michael Lindquist |
| ZRG1 CTH-T (81) |
Cancer Therapeutics and Drug Development
|
Dr. Lilia Topol |
| ZRG1 CTH-V (81) |
Clinical and Translational Cancer Research |
Dr. Viktoriya Sidorenko |
| ZRG1 CTH-X (81) |
Clinical and Translational Cancer Research |
Dr. Shuli Xia |
| ZRG1 CTH-Z (45) |
Program Project: Cancer Research |
Dr. Caterina Bianco |
| ZRG1 DCAI-B (50) |
PAR Panel: Review of Support for Research Excellence (SuRE) (R16) and SuRE-First Independent Research (SuRE-First) (R16) applications |
Dr. Shinako Takada |
